Curran Terrie
SEC CIK 1690298 · EDGAR
BoughtSold
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-28 17:40 | 2026-08-27 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | M - OptEx | $8.30 | +38.2K | 50.6K | +309% | +$317.2K |
| DM | 2026-08-28 17:40 | 2026-08-27 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | S - Sale+OE | $25.03 | -38.2K | 23.5K | -62% | -$956.1K |
| D | 2026-08-24 16:19 | 2026-08-20 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | M - OptEx | $7.51 | +1,072 | 24.6K | +5% | +$8,051 |
| D | 2026-08-24 16:19 | 2026-08-20 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | S - Sale+OE | $26.04 | -1,072 | 23.5K | -4% | -$27.9K |
| D | 2026-06-09 21:21 | 2026-06-05 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | A - Grant | $0.00 | +5,778 | 23.5K | +33% | $0 |
| D | 2025-06-16 | 2025-06-12 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | A - Grant | $0.00 | +7,609 | 17.7K | +75% | $0 |
| 2025-01-23 | 2025-01-21 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | S - Sale | $6.59 | -19.1K | 360.5K | -5% | -$125.9K | |
| 2024-11-13 | 2024-11-11 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | S - Sale | $10.85 | -8,687 | 10.1K | -46% | -$94.3K | |
| 2024-07-17 | 2024-07-15 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | S - Sale | $11.72 | -33.8K | 377.7K | -8% | -$396.7K | |
| D | 2024-06-18 | 2024-06-14 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | A - Grant | $0.00 | +10.1K | 18.8K | +117% | $0 |
| 2024-03-26 | 2024-03-22 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | S - Sale | $9.11 | -16.9K | 410.8K | -4% | -$153.5K | |
| 2023-11-03 | 2023-11-01 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | A - Grant | $0.00 | +37.5K | 427.2K | +10% | $0 | |
| D | 2023-07-17 | 2023-07-14 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | A - Grant | — | +200.0K | 389.7K | +105% | — |
| D | 2023-06-02 | 2023-05-31 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | A - Grant | $0.00 | +4,375 | 8,687 | +101% | $0 |
| 2023-04-07 | 2023-04-06 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | P - Purchase | $7.82 | +12.9K | 188.3K | +7% | +$101.0K | |
| 2023-03-03 | 2023-03-01 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | S - Sale | $8.54 | -1,436 | 175.4K | -0.8% | -$12.3K | |
| D | 2023-01-20 | 2023-01-19 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | A - Grant | $0.00 | +97.5K | 182.6K | +115% | $0 |
| D | 2023-01-20 | 2023-01-20 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | S - Sale | $8.20 | -5,821 | 176.8K | -3% | -$47.7K |
| 2022-11-23 | 2022-11-21 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | S - Sale | $9.60 | -1,526 | 83.7K | -2% | -$14.6K | |
| 2022-09-02 | 2022-09-01 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | A - Grant | $0.00 | +7,500 | 85.2K | +10% | $0 | |
| D | 2022-06-03 | 2022-06-01 | ARQT | Arcutis Biotherapeutics, Inc. | Curran Terrie | Dir | A - Grant | $0.00 | +4,312 | 4,312 | New | $0 |
| 2022-05-20 | 2022-05-19 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | A - Grant | $0.00 | +12.0K | 76.6K | +19% | $0 | |
| 2022-05-16 | 2022-05-13 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | P - Purchase | $7.41 | +20.5K | 64.6K | +46% | +$151.9K | |
| D | 2022-01-21 | 2022-01-19 | PHAT | Phathom Pharmaceuticals, Inc. | Curran Terrie | Pres, Chief Executive, Dir | A - Grant | $0.00 | +41.2K | 44.1K | +1,450% | $0 |
Purchase Sale Sale after option exercise All abbreviations